(Press-News.org) DETROIT (Sept. 27, 2023) – Henry Ford Health is the first health system in Michigan to offer ExactVu, a cutting-edge technology for diagnosing and evaluating prostate cancer. Enhancing the precision and speed of diagnosis, this new technology ensures patients receive timely and appropriate care, while also providing a more efficient and convenient experience than other diagnostic methods.
"Throughout the years, advancements in prostate cancer diagnostic and treatment modalities have made a tremendous difference for patients,” said Craig Rogers, M.D., Chair of the Department of Urology at Henry Ford Cancer. “This is another step forward, making it possible to not only expedite diagnosis, but also make that process easier for our patients. Our program at Henry Ford has always been at the forefront of prostate cancer care, and the addition of this new technology is a testament to our team’s dedication to ensuring our patients have access to the best care available."
ExactVu visualizes details previously not visible on prostate ultrasound images, detects prostate abnormalities in real-time, and takes a biopsy sample of suspicious areas. Lee Gardner, 72, of Northville, Michigan, is among the first Henry Ford patients to benefit from this new technology. He’s thriving after a successful prostate procedure in August.
“I’m thankful to my primary care physician, Dr. Clark Creger, for his referral to a specialist when he suspected something was wrong with my prostate, and to Dr. Craig Rogers, for accurately diagnosing the problem and walking me through the available options,” said Gardner.
Utilizing ExactVu, a suspicious area was identified on the right side of Gardner’s prostate, and a targeted biopsy confirmed the presence of cancer. Soon after, Gardner underwent a successful High Intensity Focused Ultrasound (HIFU) procedure on the right side of his prostate.
HIFU is a non-invasive therapeutic technique that employs ultrasound waves to target and treat specific areas of the prostate, eliminating cancerous tissues while leaving the surrounding region unharmed. Patients benefit from HIFU due to its precise targeting, reduced side effects and quicker recovery times.
“Getting a correct diagnosis was a key part of helping me decide which option was best. I’m feeling wonderful, and grateful to be back to living the active lifestyle I’ve enjoyed for many years,” Gardner said.
To learn more about prostate cancer care at Henry Ford Health, visit Henryford.com/Prostate Cancer.
END
Henry Ford Health first in Michigan to introduce advanced prostate diagnostic technology
New platform can speed up prostate cancer diagnostic process for patients.
2023-09-27
ELSE PRESS RELEASES FROM THIS DATE:
Resolving a seeming contradiction, study advances understanding of visual recognition memory
2023-09-27
Because figuring out what is new and what is familiar in what we see is such a critically important ability for prioritizing our attention, neuroscientists have spent decades trying to figure out how our brains are typically so good at it. Along the way they’ve made key observations that seem outright contradictory, but a new study shows that the mystifying measures are really two sides of the same coin, paving the way for a long-sought understanding of “visual recognition memory” (VRM).
VRM is the ability to quickly recognize the familiar things in scenes, which can then be de-prioritized so that we can focus on the new things that might be more important ...
The Buck Institute and Phenome Health announce major strategic partnership
2023-09-27
The Buck Institute for Research on Aging and Phenome Health are joining forces in the quest to understand the biology of aging. Phenome Health, a Seattle-based nonprofit research organization led by CEO Lee Hood, MD, PhD, uses a data-driven approach to health and disease that integrates diverse types of biological big data. The new Center for Phenomic Health at the Buck will be co-led by Dr. Hood, who joins the Buck as Chief Innovation Officer and Distinguished Professor, and Eric Verdin, MD, Buck President ...
Revolutionary breakthrough: human stomach micro-physiological system unveiled
2023-09-27
A groundbreaking development in biomedical engineering has led to the creation of a human stomach micro-physiological system (hsMPS), representing a significant leap forward in understanding and treating various gastrointestinal diseases, including stomach cancer. The research team, led by Professor Tae-Eun Park from the Department of Biomedical Engineering at UNIST and Professor Seong-Ho Kong from Seoul National University Hospital, has successfully developed a biomimetic chip that combines organoid and organ-on-a-chip technologies to simulate the complex defense mechanisms of the human gastric mucosa.
Organoids, which mimic human organs using stem cells, have ...
ORNL launches Center for AI Security Research to study AI’s impacts on society, security
2023-09-27
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of its Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making.
In partnership with federal agencies such as the Air Force Research Laboratory’s Information Directorate and the Department of Homeland Security (DHS) Science and Technology Directorate ...
Extreme weight loss: Star sheds unexpected amounts of mass just before going supernova
2023-09-27
Cambridge, Mass. — A newly discovered nearby supernova whose star ejected up to a full solar mass of material in the year prior to its explosion is challenging the standard theory of stellar evolution. The new observations are giving astronomers insight into what happens in the final year prior to a star’s death and explosion.
SN 2023ixf is a new Type II supernova discovered in May 2023 by amateur astronomer Kōichi Itagaki of Yamagata, Japan shortly after its progenitor, or origin star, ...
Target: BP™ intitiative helps more than 8.6 million Americans with hypertension improve heart health
2023-09-27
DALLAS, September 27, 2023 — The American Heart Association and American Medical Association (AMA) nationally recognized 1,709 health care organizations (HCOs) — 400 more than in 2022 — for their efforts to prioritize control of their patients’ blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature death.
According to the 2022 American Heart Association Statistical Update, nearly half of U.S. adults — 121.5 million ...
Tiny CRISPR tool could help shred viruses
2023-09-27
HOUSTON – (Sept. 27, 2023) Small and precise: These are the ideal characteristics for CRISPR systems, the Nobel-prize winning technology used to edit nucleic acids like RNA and DNA.
Rice University scientists have described in detail the three-dimensional structure of one of the smallest known CRISPR-Cas13 systems used to shred or modify RNA and employed their findings to further engineer the tool to improve its precision. According to a study published in Nature Communications, the molecule works differently than other proteins in the same family.
“There are different types of CRISPR systems, and the one ...
Plastic cloud: New study analyzes airborne microplastics in clouds
2023-09-27
Plastic particles less than 5 mm in size are called “microplastics.” These tiny bits of plastic are often found in industrial effluents, or form from the degradation of bulkier plastic waste. Research shows that large amounts of microplastics are ingested or inhaled by humans and animals alike and have been detected in multiple organs such as lung, heart, blood, placenta, and feces. Ten million tons of these plastic bits end up in the ocean, released with the ocean spray, and find their way into the atmosphere. This implies that microplastics may have become an essential component of clouds, ...
Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance new combination therapy challenge announced
2023-09-27
ARLINGTON, Va., September 27, 2023 — The American Society for Radiation Oncology (ASTRO) today announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge. The Challenge aims to identify research that addresses ways prostate cancer treatments can be improved with the gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix in patients who received radiation therapy.
The Challenge invited researchers to propose the study of relugolix in different scenarios: ...
New evidence for sub-network specializations within the Default Mode Network and the Special Role of Facial Movements in Brain Activation and Self-Perception
2023-09-27
Recent advancements in neuroscience have unveiled new insights into the neural processes responsible for self-referential cognition. This research has brought particular attention to a critical neural network known as the Default Mode Network (DMN), comprising brain regions such as the medial prefrontal cortex (mPFC), posterior cingulate cortex, temporoparietal junction (TPJ), and both lateral and medial temporal lobes.
Central to self-related processing, is the information associated with one’s ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] Henry Ford Health first in Michigan to introduce advanced prostate diagnostic technologyNew platform can speed up prostate cancer diagnostic process for patients.